Beta-blocker use is not associated with slow flow during rotational atherectomy

J Invasive Cardiol. 2012 Aug;24(8):379-84.

Abstract

Objectives: The purpose of this study was to investigate the association between beta-blocker use and slow flow during rotational atherectomy (RA).

Background: RA is often performed as part of percutaneous coronary interventions for the treatment of calcified lesions; however, the procedure can be complicated by slow flow. Previous reports suggested that the use of beta-blockers was associated with slow flow during RA.

Methods: A total of 186 patients who received RA were included, and 87 patients were on beta-blockers. The occurrence of slow flow was compared between the beta-blocker group (n = 87) and the non-beta-blocker group (n = 99). Multivariate logistic regression analysis was performed to investigate whether the use of beta-blockers was associated with slow flow.

Results: The occurrence of slow flow was not different between the beta-blocker group (29.9%) and the non-beta-blocker group (24.2%; P=.39). The use of beta-blockers was not significantly associated with slow flow (odds ratio, 0.75; 95% confidence interval, 0.34-1.68; P=.49) after controlling for all potential confounding factors.

Conclusions: There was no definitive association between slow flow and the use of beta-blockers during RA. There is no need to discontinue beta-blockers in patients receiving RA.

MeSH terms

  • Adrenergic beta-Antagonists / administration & dosage
  • Adrenergic beta-Antagonists / adverse effects*
  • Aged
  • Atherectomy, Coronary / adverse effects*
  • Atherectomy, Coronary / methods
  • Calcinosis / pathology
  • Calcinosis / physiopathology
  • Calcinosis / surgery
  • Confounding Factors, Epidemiologic
  • Coronary Angiography
  • Coronary Artery Disease / pathology
  • Coronary Artery Disease / physiopathology
  • Coronary Artery Disease / therapy*
  • Coronary Vessels / diagnostic imaging
  • Coronary Vessels / physiopathology
  • Coronary Vessels / surgery*
  • Female
  • Humans
  • Male
  • Middle Aged
  • No-Reflow Phenomenon* / diagnosis
  • No-Reflow Phenomenon* / epidemiology
  • Odds Ratio
  • Percutaneous Coronary Intervention / methods
  • Postoperative Complications* / diagnosis
  • Postoperative Complications* / epidemiology
  • Treatment Outcome

Substances

  • Adrenergic beta-Antagonists